Background: A significant increase in the use of intracytoplasmic sperm injection (ICSI) since its introduction in 1992 has been observed worldwide, including beyond its original intended use for severe male factor infertility. Concerns regarding ICSI include the effects of poor quality spermatozoa on offspring health and future fertility, and of the technique itself. The health and development of ICSI-conceived children beyond early infancy have not been comprehensively assessed. Objective: A systematic review of health outcomes of ICSI-conceived offspring beyond the neonatal period compared to spontaneously conceived (SC) offspring. Design: PubMed, OVID Medline/Embase, InformIT, Web of Science, and ProQuest databases were searched for studies reporting on health outcomes in ICSI-conceived offspring beyond 28 days after birth. Main outcomes measure(s): Physical and psychosocial health. Results: The search strategy yielded 2826 articles. Of these, 2580 were not relevant or did not meet inclusion criteria and 138 were duplicates. One hundred and eight full-text papers were evaluated further, and 48 satisfied the inclusion criteria. Most studies reported on neurodevelopment during early infancy and childhood with reassuring results. Growth, vision, and hearing of ICSI and SC offspring also appear comparable, although important differences in general physical health, and particularly metabolic and reproductive health have been described, including recently poorer semen quality among ICSI-conceived young adult men compared to SC peers. Conclusion: Whilst neurodevelopment, growth, vision, and hearing appear similar between ICSI and SC children, evidence suggests differences in general physical health, and metabolic and reproductive endpoints. The clinical significance of many findings, however, remains unclear, and further prospective, large, and good quality studies with a focus on all these health outcomes in ICSIconceived young adults are required.
INTRODUCTION
Infertility is common, affecting up to 15% of couples of reproductive age (de Kretser, 1997) and the male contribution is substantial, accounting for at least 30% of cases (Ferlin et al., 2007) . Despite significant advances in assisted reproductive technology (ART), our understanding of the etiology of male factor infertility remains incomplete. As such, there is a paucity of targeted therapies and most men must resort to 'bypass strategies' such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). ICSI has been in clinical use since 1992, initially solely for management of male factor infertility; however, its use has escalated globally and now often used beyond its original intended indication (Palermo et al., 1992; Dyer et al., 2016) . Concerns regarding this increased use include the effects of poor quality spermatozoa on offspring health and future fertility, and the ICSI procedure itself, including potential effects on the epigenetics of early embryogenesis.
ICSI and IVF conceptions are associated with an increased risk of preterm delivery, low birthweight, multiple births, fetal growth restriction, maternal complications, and neonatal morbidity compared to spontaneous conception (Pandey et al., 2012; Qin et al., 2015) . Meta-analyses provide persuasive evidence of a greater risk of congenital malformations (Hansen et al., 2005 (Hansen et al., , 2013 Wen et al., 2012; Qin et al., 2015) , and increased rates of imprinting disorders have also been reported (Lazaraviciute et al., 2014) . Health outcomes beyond the neonatal period, however, are less well defined. Some physiological differences between ART-conceived adolescents and young adults have been identified, such as blood pressure (BP), but overall their general health and psychosocial outcomes appear similar (Wilson et al., 2011) . To our knowledge, a systematic review of longer term health outcomes for children conceived using ICSI compared to spontaneous conception has not yet been published.
With increasing use of ICSI worldwide, the need to understand any potential adverse effects on offspring health is critical. The objective of this manuscript was to systematically review the available evidence on health outcomes in ICSI compared to SC offspring beyond the neonatal period. A discussion of studies comparing health outcomes between ICSI-and IVF-conceived children has previously been published (Catford et al., 2017) . This review will serve as an adjunct to our previous paper, aimed to advance knowledge about the health implications of ICSI, and subsequently translate to improved couple counseling prior to ART and clinical practice. It will also encourage additional research into male infertility and direct researchers to areas requiring further investigation.
METHODOLOGY
The methodology used in this review is identical to that used previously (Catford et al., 2017) . A literature search of online databases including PubMed, OVID Medline/Embase, InformIT, Web of Science, and ProQuest was performed on May 9, 2017. Searches were performed for all study types published in the English language using relevant MeSH headings and keywords: ('sperm injections, intracytoplasmic/' OR 'ICSI' OR 'intra-cytoplasmic sperm injection' OR 'intracytoplasmic sperm injection') AND ('child' OR 'children' OR 'offspring' OR 'adolescent*' OR 'follow' OR 'follow-up'). Articles were screened by title and abstract, and full-text articles were then assessed for eligibility.
Inclusion criteria were original studies that reported on health outcomes in ICSI-conceived offspring beyond the neonatal period, defined as 28 days after birth, compared to SC offspring. Studies were excluded if they presented grouped data on IVFand ICSI-conceived offspring, not allowing for extraction of ICSI data. Studies reporting on perinatal and later outcomes were included, but only data relating to health beyond the neonatal period were extracted for analysis. Studies focused on offspring of fathers with a known genetic cause of infertility, such as Klinefelter's syndrome or Y chromosome microdeletions, were excluded. Meta-analyses, systematic reviews, and case reports were also omitted from our analysis. Studies of contention were few and differences resolved by consensus. We reviewed the reference lists of all meta-analyses and systematic review meeting criteria to identify additional potential references.
Data were extracted by standard form from all studies according to PRISMA guidelines (Moher et al., 2015) . We assessed the quality of included studies using the Newcastle-Ottawa Scale (NOS) (Wells et al. 2016) . The NOS contains eight items, which are incorporated into three categories including selection, comparability, and outcome for cohort studies. Total scores were converted to the Agency for Healthcare Research and Quality (AHRQ) standards to indicate whether a study was of good, fair, or poor quality. Differences were resolved by consensus. Descriptive statistics were performed using MICROSOFT EXCEL (Version 10.11.6, Microsoft Corporation, Redmond, WA, USA).
RESULTS
A PRISMA flow diagram outlining the review process is presented in Figure S1 . The search strategy yielded 2826 articles. Of these, 2580 were not relevant or did not meet inclusion criteria and 138 were duplicates. One hundred and eight full-text papers were evaluated further, and 48 satisfied the inclusion criteria. Of the 60 eliminated papers, 16 reported on only ICSI-compared to IVF-conceived offspring and have been discussed previously {Catford:2017gj}, and seven reported on ICSI-conceived offspring without a SC-or IVF-conceived control group (Bonduelle et al., 1998; Pruksananonda, 2001; Neri et al., 2007; De Schepper et al., 2009; Belva et al., 2010; Tsai et al., 2011 Tsai et al., , 2015 . Two studies did not directly compare ICSI and SC children (Schendelaar et al., 2014; Spangmose et al., 2017) . A further 35 papers were eliminated; details of their exclusion rationale are as previously published (Catford et al., 2017) . Although many of the included studies had IVF in addition to SC offspring as a study group, for the purpose of this review only results comparing ICSI and SC offspring will be presented. The quality of the 48 selected studies was assessed using the NOS scoring system for cohort studies (Table S1 ).
Neurodevelopment
Twenty-four articles published between 1998 and 2016 (median 2005) reported on neurodevelopment in ICSI compared to SC infants at a median age (range) of 3.5 (0.75-10) years; thirteen included IVF-conceived infants as an additional control group (Table 1) . The average quality of the selected papers was good (median total NOS score 7, range 5-9). Median sample sizes (range) were 103 (15-553) and 106 (29-37,897) for ICSI and SC groups, respectively. Most presented reassuring results and used a range of tools to assess cognitive and motor development, such gestational age, parity, and plurality, parents of ICSI-conceived children were less educated and a higher proportion were nonnative English speakers, yet there was no adjustment for parent education, primary language, or maternal occupation in subgroup analyses. Lack of blinding, age at assessment, and insufficient power also diminished the quality of this study. Later assessment of this cohort at 5 years of age with an improved study design and using the WPPSI-R found no differences in fullscale, verbal, or performance intelligence quotients (IQ) or prevalence of delayed development between ICSI and SC groups (Leslie et al., 2003) . Differences in the Bayley Scales of Infant Development were also noted in a small cross-sectional cohort of 1-year-old ICSIconceived children who scored lower Behavioural Index scores in the motor quality item than their SC counterparts (La Sala et al., 2004 ). Yet this difference was attenuated at 2 years of age, and there were no differences in mental or motor development overall or at any time point. This study also did not adjust for prematurity and plurality.
In a multinational prospective review of 300 ICSI-conceived singletons aged 5 years, Ponjaert-Kristoffersen et al. (2004) found that, compared to a matched cohort of SC children, ICSI-conceived children more often obtained a score below one standard deviation of the mean on three visual-spatial subsets of the WPPSI-R performance scale, which was not explained by gestational age or birthweight (Ponjaert-Kristoffersen et al., 2004). However, overall there were no significant differences in cognitive development between the two groups as indicated by similar verbal, performance and full-scale IQ scores.
In a similarly large multicenter study of 5-year-old singletons, subgroup analysis of firstborn children with maternal age at birth between 33 and 45 years, suggested that those of ICSI conception had poorer verbal and cognitive development, after adjustment for maternal education (Ponjaert-Kristoffersen et al., 2005) . However, differences in IQ scores were less than one point, and overall, there was no difference in cognitive and motor function between groups.
The possibility of poorer cognitive function following ICSI conception was also highlighted by Knoester et al., who by contrast found a significantly lower IQ using the Revised Amsterdam Child Intelligence Test (RAKIT) in 86 ICSI-conceived singletons aged 5 to 8 years compared to 85 matched SC controls with an adjusted mean difference of 5-7 depending on covariates used in the model; adjustment for confounders including prematurity did not alter results (Knoester et al., 2008a) . However, the mean IQ of ICSI-conceived infants still fell in the normal range.
Few studies have attempted to define the relative contribution of infertility and ART to neurodevelopment. In a large prospective study of singletons born of planned pregnancies, Zhu et al. (2009) examined developmental milestones as a function of time to pregnancy (TTP) and infertility treatment by comparing developmental progress at 18 months, by maternal questionnaire, of children of fertile couples (TTP ≤12 months), infertile couples who conceived naturally (TTP >12 months), and couples who underwent infertility treatment (Zhu et al., 2009) . The ART group overall, which included children born after ICSI, IVF, intrauterine insemination, and hormonal therapy, had a slight delay in cognitive development compared to children born to infertile couples who conceived naturally, and ICSI-conceived children had the highest risk of delay for most milestones compared to the other ART treatments. Further research with more objective measures of development is required before inferences can be drawn.
Several studies have also examined behavior and family relations among ICSI-conceived children with no indication of concern (Barnes et al., 2004; La Sala et al., 2004; The clinical significance of the aforementioned findings is uncertain, if not inconsequential and overwhelmingly evidence suggests there are no significant differences in neurodevelopment between ICSI and SC children, as indicated by the remaining 17 studies (Sutcliffe et al., 1999 (Sutcliffe et al., , 2001 (Sutcliffe et al., , 2003 Leslie et al., 2003; Place & Englert, 2003; Barnes et al., 2004; Papaligoura et al., 2004; Agarwal et al., 2005; Leunens et al., 2006 Leunens et al., , 2008 Knoester et al., 2007a,b; Sanchez-Albisua et al., 2007; Palermo et al., 2008; Ludwig et al., 2009a; Faramarzi et al., 2016) .
Summary
A review of 24 studies of mostly good quality strongly suggests that ICSI and SC children are comparable in neurodevelopment as indicated by similar cognitive and motor performance, and in some studies behavior and family relations. Significant differences are reported in only seven studies, the majority of which present clinically insignificant findings or have important methodological limitations (Bowen et al., 1998; La Sala et al., 2004; Ponjaert-Kristoffersen et al., 2004 Sanchez-Albisua et al., 2007; Knoester et al., 2008a) .
Reproductive health
Seven studies published between 2007 and 2017 (median 2012) have evaluated reproductive health at a median age of 14 (0.25-20) years (Table 2) . Median sample sizes were 71 (54-217) and 81 (57-933) for ICSI and SC groups, respectively. The average quality of the selected papers was fair (median total NOS score 6, range 6-7).
Until recently, the reproductive health of ICSI-conceived children had not been assessed beyond puberty. First results revealed lower serum testosterone and higher LH-to-testosterone ratios in ICSI-conceived 3-month-old sons of infertile fathers compared to age-matched SC males, whereas no difference in these values was observed between IVF-conceived males selected for female infertility and SC males (Mau Kai et al., 2007) . Adjusted analyses for confounders including twinning did not alter results. Serum FSH, LH, and inhibin B levels though were comparable. Another study compared finger length and digit ratio between ICSI and SC children aged 4 to 9 years, as a possible indicator of future fertility, as shorter finger length has been described in azoospermic men . Digit length is regulated by Homeobox (HOX) genes expressed during embryogenesis; mutations in HOX genes are associated with distal limb abnormalities and have also been implicated in the pathogenesis of male infertility . In this cohort, ICSI-conceived children had significantly shorter second and fourth digit lengths after correction for height compared to age-matched SC children and a tendency for a higher second-tofourth digit ratio.
Later studies were reassuring. Although breast development was found to be less advanced in ICSI-conceived females compared to SC females at 14 years in a cross-sectional examination, pubertal development was otherwise comparable in both sexes, as determined by parent questionnaire and physical examination (Belva et al., 2012c) . Furthermore, normal Leydig and Sertoli cell function measured by salivary testosterone and serum inhibin B was documented in pubertal ICSI-conceived boys compared to SC peers (Belva et al., 2011) . In the latter study, testosterone levels between boys of fathers with or without severe oligozoospermia also did not differ, and no correlation between testosterone levels and paternal semen parameters was evident.
The first results of semen quality, however, revealed a significantly lower median sperm concentration (17.7 vs. 37 million/ mL, p = 0.004), total sperm count (31.9 vs. 86.8 million, p = 0.001), and total motile sperm count (12.7 vs. 38.6 million, p = 0.002) in 54 ICSI-conceived adult men aged 18-22 years compared to 57 age-matched SC controls (Belva et al., 2016) . After adjustment for important covariates such as abstinence period, sperm concentration (OR 1.9, 95% CI 1.1-3.2, p = 0.02), total sperm count (OR 2.3, 95% CI 1.3-4.1, p = 0.005), and total motile count (OR 2.1, 95% CI 1.2-3.6, p = 0.007) remained significantly higher in SC men. Moreover, ICSI-conceived men were almost three times more likely to have sperm concentrations <15 million/mL (AOR 2.7, 95% CI 1.1-6.7, p = 0.035) and four times more likely to have total sperm counts <39 million (AOR 4.3, 95% CI 1.7-11.3, p = 0.002). The risk of abnormal sperm morphology also tended to be higher in the ICSI group (AOR 2.3, 95% CI 0.9-5.4, p = 0.06). Interestingly, unfavorable paternal semen parameters were not predictive of impaired spermatogenesis in sons. Reproductive hormone levels were also reported in this cohort of ICSI-conceived young men (Belva et al., 2017a) . Compared to their SC peers, ICSI men had comparable levels of FSH, LH, testosterone, and inhibin B after adjustment for confounders. They were more likely to have inhibin B levels below the 10th percentile (AOR 4.0, 9%% CI 0.9-18.4, p = 0.07) and FSH levels above the 90th percentile (AOR 3.3, 95% CI 0.9-11.9, p = 0.06), but neither difference reached statistical significance.
More recently, Belva et al. reported the first results of serum reproductive hormone levels and ultrasound findings in female offspring of ICSI conception aged 18 to 22 years (Belva et al., 2017b) . Compared to age-matched SC women, median levels of serum AMH, FSH, LH and DHEAS, and mean follicle count per ovary as assessed by ultrasound were similar. Whilst reassuring, this study was limited by single blood measurements, poor information on hormonal contraceptives, and did not perform ultrasound scans and hormone analysis in the early phase of menses.
Summary
Studies of fair quality assessing pubertal ICSI-conceived offspring are reassuring, but they are limited by incomplete gonadal and cross-sectional assessment. Recent evidence suggests impaired spermatogenesis in ICSI-conceived young adult males, as indicated by reduced semen quality, and possibly higher FSH and lower inhibin B levels, compared to their SC peers. The fertility of ICSI-conceived males and the extent of transgenerational inheritance of infertility, however, remain unknown. Further studies of semen quality and pregnancy data are needed.
General physical health
Six studies published between 2004 and 2016 (median 2007) assessed general physical health at a median age of 5.75 (5-13.5) years; all children were singletons (Table 3) . Median sample sizes of ICSI and SC groups were 288 (87-2389) and 269 (85-541,641), respectively. The average quality of the selected papers was fair (median total NOS score 6, range 5-8). Except for one registry study (Kettner et al., 2016) , outcome measures were based on parent questionnaires and clinical reviews. Four studies found significant differences between ICSI and SC children. Whilst analyses adjusted for important child and maternal confounders, shared limitations of these studies include frequent lack of blinding, survivor bias, variation in recruitment of study groups (selection bias), poor participation rate, and recall bias with possible over reporting of health concerns by ICSI mothers.
Several European cohort studies have reported higher rates of surgical interventions, illnesses, hospitalizations, and need for medical therapy in ICSI-conceived children. In a retrospective multicenter review of 300 ICSI and 266 SC children at 5 years of age, more ICSI children required surgical interventions (23 vs. 16.5%, p = 0.02), which was explained by a higher rate of minor ear problems . Requirement for medical therapies, such as physiotherapy and speech therapy, was also greater in the ICSI group (13.6 vs. 6.2%, p = 0.012). Another multicenter cohort study of 5-year-olds reported significant increases in the rate of childhood illness, need for surgery and medical therapy, and hospital admissions in 540 ICSI-conceived children compared to 538 matched SC children . Finally, a prospective review of children aged 4 to 6 years of at least 37-week gestation found a significantly increased risk of undescended testes (5.4 vs. 0.7%, p = 0.03), more urogenital surgeries (19.2 vs. 8.9%, p = 0.013), and more hospital admissions (37.6 vs. 27.2%, p = 0.006) in the ICSI group compared to well-matched SC children (Ludwig et al., 2009b) .
Other groups have found no differences in general health, need for medical therapy, surgery, or hospitalizations, although sample sizes were smaller and assessments performed at a slightly older age, potentially increasing the risk of survivor and selection bias (Belva et al., 2007; Knoester et al., 2008b) . The Belgium cohort study, however, did find a significantly higher diastolic blood pressure (DBP) and systolic blood pressure (SBP) in ICSI compared to SC children matched for age, sex, and maternal education (SBP 100 vs. 95 mmHg, p < 0.001; DBP 60 vs. 55 mmHg, p < 0.001), but only single BP measurements were performed (Belva et al., 2007) .
The potential for diverse adverse long-term health outcomes, as a consequence of epigenetic phenomena related to the ICSI technique itself or parental factors, is well recognized. One study has addressed the prevalence of type 1 diabetes mellitus (T1DM) among adolescents of ART conception. This nationwide Danish birth cohort study found no association between ICSI (and other fertility treatments) and T1DM (Kettner et al., 2016) .
Summary
Fair quality data suggest that ICSI-conceived offspring may be at increased risk of surgical interventions, urogenital surgeries, undescended testes, childhood illnesses, hospital admissions, and need for medical therapies compared to SC children. However, the sources of this evidence are limited to childhood assessments and rely partially on parent reports, which are inherently subject to recall bias. Future research involving data collection from ICSI-conceived young adults is necessary.
Metabolic health
Five studies published between 2012 and 2017 (median 2013) compared metabolic outcomes in ICSI and SC offspring at a median age of 14 (2.5-14) years with median sample sizes of 201 (42-284) and 223 (42-320) for ICSI and SC groups, respectively (Table 4) . The average quality of the selected papers was fair (median total NOS score 7, range 7-7). Outcome measures comprised anthropometry, blood pressure, cortisol, and cardiometabolic measurements including plasma metabolomics.
Assessment of adiposity in a Belgium cohort of adolescent singletons revealed greater peripheral adiposity in ICSI-conceived boys with advanced pubertal stages compared to SC boys and significantly higher measures of peripheral, central, and total adiposity in ICSI-conceived girls compared to SC girls (Belva et al., 2012a) . Additionally, a recent longitudinal study on body mass index (BMI) trajectory during childhood showed ICSI-conceived children between 1 and 2 years of age to have a lower mean BMI decrease compared to SC children (Meddeb et al., 2017) . The difference was not clinically significant and BMI until 5 years of age was similar between groups, but data were extracted from medical records and 644 Andrology, 2018, 6, 635-653 limited by attrition and a decrease in consecutive measures after 2 years.
Glucocorticoids are important mediators of obesity and insulin resistance, and disruption of the hypothalamic-pituitaryadrenal axis has been proposed as a mechanism for unfavorable metabolic outcomes after in vitro conception (Belva et al., 2013) .
Interestingly, lower salivary and serum cortisol levels have been reported in ICSI-conceived girls compared to SC girls, although these results were based on single measurements (Belva et al., 2013; Gkourogianni et al., 2014) . Mean salivary cortisol in the Belgium cohort was lower in ICSI-conceived girls, which remained after adjusting for current characteristics, and early life 27.2%, p = 0.006) (no specific reason); no differences in incidence of childhood diseases, acute and chronic illnesses, accidents and overall surgeries 6 Fair aHR, adjusted hazards ratio; AHRQ, Agency for Health Research and Quality; BW, birthweight; DBP, diastolic blood pressure; GA, gestational age; IUI, intrauterine insemination; NOS, Newcastle-Ottawa Scale; OI, ovulation induction; PR, participation rate; S, singleton birth; SBP, systolic blood pressure; SC, spontaneously conceived; T1DM, type I diabetes mellitus.
a Also reported perinatal and/or obstetric outcomes and/or congenital malformations.
© 2018 American Society of Andrology and European Academy of Andrology Andrology, 2018, 6, 635-653 SC boys (difference 3.5 mm, 95% CI 0.3-6.6) and higher % body fat mass (difference 2.1%, p < 0.05) Girls: Peripheral, central, total adiposity, mean MUAC and waist circumference significantly higher in ICSI girls vs. SC girls after adjusting for confounders (difference 2.8 mm, 3.1 mm, 6.3 mm, 1.5 cm and 2.1 cm, all p < 0.05); higher BMI and % body fat mass in ICSI girls vs. SC girls after adjustment (difference 1.1 kg/m2, 1.8%, p < 0.01) 143.5 ng/dL, p = 0.0007) and lower cortisol (8.6 vs. 17.9 lg/dL, p = 0.02) in ICSI (n = 10) vs. SC girls (n = 9); significant differences, characterized by 36 metabolites, indicating early insulin resistance in ICSI girls 7 Good
Meddeb et al. AHRQ, Agency for Health Research and Quality; BP, blood pressure; BW, birthweight; GA, gestational age; GC-MS, Gas chromatography-mass spectrometry; M, multiple birth; NOS, Newcastle-Ottawa Scale; PR, participation rate; S, singleton birth; SBP, systolic blood pressure; SC, spontaneously conceived.
a Also reported perinatal and/or obstetric outcomes and/or congenital malformations (CM).
and maternal factors (Belva et al., 2013) . In a smaller cohort, an extensive review of plasma metabolomics also revealed lower cortisol levels in a subgroup of ICSI-conceived girls aged 4 to 9 years compared to SC girls, alongside significant differences in 36 metabolites indicating early insulin resistance in the ICSI group (Gkourogianni et al., 2014) . Another unexpected finding in this latter study was lower inflammatory markers in the ICSI group compared to SC controls including YKL-40, which normally represents a marker of inflammation, obesity, and insulin resistance (Gkourogianni et al., 2014) . Collectively, these findings have been suggested to reflect an adaptive mechanism to counter the increased insulin resistance after ICSI conception, thereby maintaining metabolic homeostasis (Belva et al., 2013; Gkourogianni et al., 2014) .
Despite suggestions of heightened metabolic risk, no significant differences in resting BP and BP in response to stress were found in the same Belgium cohort of 14-year-old ICSI and SC offspring after repeated measurements and adjustment for early life and parental factors (Belva et al., 2012b) . These results contradict those of Belva's previous study of 8-year-old ICSI-conceived children who were found to have higher BP recordings than their SC peers (Belva et al., 2007) .
Summary
Several studies of fair quality suggest ICSI-conceived offspring are more prone to adiposity and early insulin resistance than their SC peers, although some results are inconsistent and require further investigation. Prospective monitoring of cardiometabolic risk in larger cohorts utilizing a variety of outcome measures is required to clarify these results.
Growth
Three studies from the UK, Denmark, and the Netherlands published between 2006 and 2011 (median 2010) examined long-term growth at a median age of 3.5 (1.6-6) years (Table 5 ). Median sample sizes of ICSI and SC groups were 201 (68-330) and 851 (70-5059), respectively. The average quality of the selected papers was poor (median total NOS score 6, range 5-7).
The UK cohort included 166 ICSI and 173 SC singletons, who underwent measurements of height and weight at regular intervals until 12 years of age . Adjusted analyses for child age, sex, gestational age, and maternal factors demonstrated no significant differences in growth between groups at any time point; however, the authors were unable to control for parental height and measurements at the latter time points relied on parent reports. In the larger Dutch cohort with a population-based SC control group, similar measurements were performed from 1 month to 4 years of age with no difference in weight between groups (Woldringh et al., 2011) . In this study, local practitioners measured the weight of SC children, yet parents reported the weight of ICSI children, introducing potential reporting bias. In the final study, ICSI-conceived children were shorter than their target height at 3 years compared to SC children, but not at 5 years (Kai et al., 2006) . In addition, serum insulin-like growth factor-1 levels were significantly lower in ICSI-conceived singleton boys compared to SC singleton boys at 3 months in this study, but no differences were identified at 5 years.
Summary
From the few studies of overall poor quality, there does not appear to be a difference in growth between ICSI and SC children.
Vision and hearing
Three studies published between 2006 and 2010 (median 2008) have investigated vision and hearing at 5 years of age (Table 6 ). Median sample sizes of ICSI and SC groups were 137 (57-276) and 159 (82-273), respectively. The average quality of the selected papers was fair (median total NOS score 7, range 6-7).
In a cross-sectional review of ocular fundus photographs, a significantly reduced number of retinal vascular branching points were identified in 5-year-old children born after ICSI compared to spontaneous conception; a gender difference was found with a lower number in ICSI-conceived boys compared to SC boys (Wikstrand et al., 2008) . The difference remained after adjustment for factors known to cause a reduced number, such as low birthweight and prematurity, indicating other mechanisms are responsible. Current evidence suggests that fewer retinal branching points can lower the threshold for the development of vascular disease in adulthood (Wikstrand et al., 2008) . Therefore, ICSI-conceived boys might be at risk of similar changes in other vasculature such as the coronary and renal vessels, increasing their risk of cardiovascular disease later in life. It is not clear why there would be a difference between ICSI and SC boys, but not girls; however, the sample size was small and more boys participated.
The two other studies revealed no significant differences in visual function, ocular morphology, and hearing as assessed by ophthalmological examination and pure tone audiometry (Wikstrand et al., 2006; Ludwig et al., 2010) .
Summary
Vision and hearing of ICSI and SC children appear comparable, as determined by studies of fair quality. However, evidence for abnormal retinal vascularization was found in one report, suggesting that ICSI-conceived offspring may be at increased risk of cardiovascular disease.
DISCUSSION

Principal findings
The use of ICSI has escalated globally, and concerns about long-term health implications have intensified in parallel. This review was designed to provide a systematic overview of the literature on the longer term health of ICSI-conceived children compared to their SC peers. Our review of 48 studies demonstrates that health outcomes beyond the neonatal period have mostly focused on neurodevelopment during infancy and childhood with reassuring results; children of ICSI and spontaneous conception appear comparable in cognitive and motor development, behavior, and family relations, as indicated by many studies of good quality. These findings are consistent with those of a recent systematic review of developmental outcomes in IVFconceived children (Hart & Norman, 2013a) . Similarly, although fewer in number and with some important limitations, studies investigating growth, vision, and hearing also suggest no harmful differences. However, there is some evidence for more surgical interventions, hospitalizations, childhood illnesses, and need for medical therapies in ICSI-conceived children compared to those of spontaneous conception Ludwig et al., 2009b) .
Interestingly, emerging data of fair quality demonstrates that ICSI-conceived offspring may be at greater cardiometabolic risk, as indicated by increased adiposity (Belva et al., 2012a) , insulin resistance (Gkourogianni et al., 2014) , differences in cortisol (Belva et al., 2013; Gkourogianni et al., 2014) , and abnormal retinal vascularization (Wikstrand et al., 2008) . The possibility of heightened metabolic risk has also been suggested in other studies of IVF-conceived offspring including another recent systematic review by Hart and Norman, with reports of higher blood pressure and triglycerides, vascular dysfunction, and glucose intolerance (Ceelen et al., 2008; Sakka et al., 2010; Hart & Norman, 2013b ). Yet, long-term follow-up data are limited and consequently it is too early to speculate about the association of ICSI, as well as standard IVF conception and metabolic risk. Ongoing investigation in larger studies into adulthood is required.
Furthermore, preliminary data from a Belgium cohort suggest impaired spermatogenesis in ICSI-conceived young adult men of mainly infertile fathers (Belva et al., 2016) . Although unfavorable paternal semen characteristics did not correlate with deficient spermatogenesis in sons, given the small sample size and complex mode of inheritance, such an observation is not unexpected. Transgenerational inheritance of male infertility is still considered likely; further studies of semen parameters, serum gonadotrophins, and fecundity are critical to determine the long-term reproductive health implications of paternal infertility. The ICSI procedure itself may also damage offspring fertility, and therefore, inclusion of a control group of men conceived by ICSI for indications other than male infertility will also be important in future research, as Belva's study was unable to separate the effects of the ICSI procedure and underlying paternal infertility.
Mechanisms for potential adverse health outcomes
So far it is not possible to determine whether the potential adverse health outcomes described are due to the ICSI technique, complications associated with IVF treatment such as prematurity, or the genetic origin of the children, that is, infertility per se. Our previous review of health outcomes in ICSI-and IVF-conceived children did not provide evidence for deleterious effects specific to ICSI conception (Catford et al., 2017) . However, methodological limitations of published studies, such as small sample size, inadequate control groups, 648 Andrology, 2018, 6, 635-653 or high nonparticipation rate; subject heterogeneity; and the complexity of ART treatment, make it difficult to isolate these effects. DNA methylation variation in human studies of ART conception supports the notion that the ICSI technique might disrupt normal epigenetic phenomena with consequences for development and long-term health (Amor & Halliday, 2008; Lazaraviciute et al., 2014) . Possible mechanisms of epigenetic changes induced by ICSI include the source, preparation, and freezing of spermatozoa; physical microinjection of a spermatozoan into an oocyte; and other factors common to all IVF procedures such as supraphysiologic hormone exposure, freezing of embryos, culture media, and growth conditions for embryos. It is also plausible that factors related to underlying subfertility rather than the procedure itself are the most important predisposing factors. For example, intrinsic errors in imprinting have been documented in spermatozoa of men with subfertility (Hammoud et al., 2010) and in oocytes of women undergoing ovulation induction (Sato et al., 2007) .
By including a control group of subfertile couples, Zhu et al., (2009) were able to explore these potential contributions with evidence suggesting the ICSI technique could be at least partly responsible for any ill health effects in offspring. They demonstrated that infertility treatment, especially ICSI, rather than underlying parental infertility, may be associated with a slight delay in some early developmental milestones. They showed that SC children born of subfertile couples had a similar pattern of psychomotor development to children of fertile couples, whereas children born after ART had a slight delay in cognitive development compared with children of subfertile couples born naturally (i.e., TTP >12 months), and ICSI conferred the greatest relative risk of delay compared to other modes of ART. This is supported by other studies that have evaluated developmental outcomes according to paternal semen characteristics and source of spermatozoa and shown no evidence of deleterious consequences in children of fathers with severe sperm abnormalities (Sutcliffe et al., 2001 (Sutcliffe et al., , 2003 Leslie et al., 2003) or children conceived using epididymal, testicular, or ejaculated spermatozoa (Bonduelle et al., 1998; Tsai et al., 2011) .
Strengths and weaknesses
Given the increasing use of ICSI worldwide, an understanding of its potential health consequences on future generations is essential. To our knowledge, this is the first systematic review on the long-term health outcomes of ICSI compared with spontaneous conception, which complements our previous evaluation Table 6 Studies reporting on vision and hearing in ICSI-and spontaneously conceived offspring of health outcomes in ICSI-and IVF-conceived offspring. Previous systematic reviews on this subject have assessed long-term health outcomes of children born from IVF including ICSI, but did not distinguish IVF and ICSI (Hart & Norman, 2013a,b) , and other reviews including a recent publication have been narrative in nature (Pereira et al., 2017) .
Many potential confounders within the literature and the varying quality of available studies limit the ability of this review to provide definitive answers. Children of ICSI conception in the majority of included studies were born to older parents, at an earlier gestation, at a lower birthweight, of higher plurality, and into a family of higher socioeconomic and educational status compared to SC children. ICSI along with IVF-conceived children is also known to be at greater risk of congenital abnormalities. All of these factors may influence health outcomes and use of medical services. Whilst the majority of studies adjusted for such child and parental factors such as gestational age and birthweight, it is very difficult to control for all potential confounders and not all relevant confounders were considered in all studies, such as plurality, parity, and double embryo transfer. Moreover, even controlling for factors such as birthweight and prematurity is far too crude and may overestimate health risks caused by ICSI treatment. For example, many studies use the definition of 'small for gestational age' to control for the potential increased neonatal morbidity of restricted fetal growth, but growth restriction may still be present in a fetus of normal weight, which could impact later onset disease. Furthermore, given the retrospective nature of many studies, unmeasured confounders are likely to have influenced results.
Other factors to consider when interpreting cohort studies are recall, selection, and participation biases, which arguably may be more apparent in research involving parents who have undergone fertility treatment. Data collection from ICSI-conceived young adults themselves will be valuable. The problem of attrition in the long-term follow-up of such cohorts is particularly challenging. Additionally, it is problematic to directly compare findings of studies in this review due to their heterogeneity in terms of outcome measures, available data, and age at assessment. Lastly, variations in ART techniques over time and between countries lead to difficulty in comparing results from the literature.
Therefore, the challenges of ongoing research in this area include (i) the requirement for multiple data sources to determine health effects; (ii) a preference for longitudinal information; (iii) sourcing of appropriate control groups; (iv) adjustment of multiple confounding, modifying, and mediating factors; (v) consideration of technological changes in the ART procedures; (vi) attention to multiple potential sources of bias; and (vii) replication and validation of health effects in numerous studies.
CONCLUSION
This systematic review of the literature provides some reassuring evidence with regard to the longer term implications of ICSI conception on offspring health. In particular, neurodevelopment of ICSI-conceived children seems comparable to SC children, as indicated by numerous studies of good quality. Data also suggest there are unlikely to be significant differences in growth, and vision and hearing, although the quality of these studies is suboptimal. However, important differences in reproductive, general physical, and metabolic health have been described in studies of fair quality that demonstrates an urgent need for longer follow-up, especially as relevant outcomes may only become apparent in adulthood. At present, it remains unclear whether observed differences are due to treatment factors, the genetic origin of the children, or related to adverse obstetric outcomes associated with IVF treatment. As such, future large cohort studies with sufficient follow-up time and adequate control populations are imperative to identify the causality of such outcomes. By improving our understanding of the health implications of ICSI conception, such research will enhance couple counseling prior to ART, improve clinical practice, and encourage further research into male infertility and fertility preservation options. Knowledge about the contribution of individual risk factors, including components of the ICSI procedure, will enable modification of clinical practice and avoidance of potential harm.
